Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDA Orange Book
0
Europe
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Meradimate
2. 134-09-8
3. Meradimate [inn]
4. Menthyl-o-aminobenzoate
5. (5-methyl-2-propan-2-ylcyclohexyl) 2-aminobenzoate
6. Anthranilic Acid, P-menth-3-yl Ester
7. Cyclohexanol, 5-methyl-2-(1-methylethyl)-, 2-aminobenzoate
8. 2-isopropyl-5-methylcyclohexyl 2-aminobenzoate
9. J9qgd60ouz
10. 5-methyl-2-(propan-2-yl)cyclohexyl 2-aminobenzoate
11. Cyclohexanol,5-methyl-2-(1-methylethyl)-, 1-(2-aminobenzoate)
12. Ncgc00159361-02
13. Dsstox_cid_27871
14. Dsstox_rid_82624
15. Dsstox_gsid_47895
16. Cas-134-09-8
17. Ccris 2468
18. Menthyl O-aminobenzoate
19. Einecs 205-129-8
20. Unii-j9qgd60ouz
21. Meradimate [usan:usp:inn]
22. Neo Heliopan Ma
23. Meradimate (usp/inn)
24. Meradimate [usan]
25. Menthyl Anthranilate, 98%
26. Meradimate [mart.]
27. Meradimate [usp-rs]
28. Meradimate [who-dd]
29. Schembl18884
30. 5-methyl-2-(1-methylethyl)cyclohexanol-2-aminobenzoate
31. Chembl1597075
32. Dtxsid3047895
33. Menthyl Anthranilate [mi]
34. Chebi:135974
35. Meradimate [usp Monograph]
36. Menthyl Anthranilate [inci]
37. Tox21_111602
38. Tox21_200561
39. Bbl028008
40. Stk083062
41. Akos001387784
42. Akos017278349
43. Db11096
44. Menthyl Anthranilate, Analytical Standard
45. Ncgc00159361-06
46. Ncgc00258115-01
47. Vs-08642
48. 2-aminobenzoic Acid P-menthane-3-yl Ester
49. Db-042217
50. Ft-0631778
51. D04927
52. Z262222228
53. 2-amino-benzoic Acid 2-isopropyl-5-methyl-cyclohexyl Ester
54. 2-aminobenzoic Acid (2-isopropyl-5-methyl-cyclohexyl) Ester
55. Meradimate, United States Pharmacopeia (usp) Reference Standard
56. Cyclohexanol, 5-methyl-2-(1-methylethyl)-, 1-(2-aminobenzoate)
57. Menthyl Anthranilate, Pharmaceutical Secondary Standard; Certified Reference Material
Molecular Weight | 275.4 g/mol |
---|---|
Molecular Formula | C17H25NO2 |
XLogP3 | 5.1 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 3 |
Rotatable Bond Count | 4 |
Exact Mass | 275.188529040 g/mol |
Monoisotopic Mass | 275.188529040 g/mol |
Topological Polar Surface Area | 52.3 Ų |
Heavy Atom Count | 20 |
Formal Charge | 0 |
Complexity | 329 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 3 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Meradimate is used as an active ingredient in sunscreens or as a sunblock factor in different products. It fits under the category of broad-spectrum absorbent agent. These characteristics are important to consider due to the fact that this kind of ingredients can either absorb or reflect UV radiation. It is also important to know the type of rays that cover. UVA rays are the responsible of causing sun damage and reaching deeper layers of the skin while UVB can only cause sunburn in the outer layer of the skin. When an agent is of broad spectrum, this means that this agent is capable of acting in both UVA and UVB rays.
Meradimate effect provides a low-level, broad-spectrum protecting coverage effect.
Absorption
Meradimate is not absorbed through the skin.
Route of Elimination
As meradimate is not absorbed, this pharmacokinetic property is not relevant.
Volume of Distribution
As meradimate is not absorbed, this pharmacokinetic property is not relevant.
Clearance
As meradimate is not absorbed, this pharmacokinetic property is not relevant.
As meradimate is not absorbed, this pharmacokinetic property is not relevant.
As meradimate is not absorbed, this pharmacokinetic property is not relevant.
Meradimate acts by absorbing both the UVA and UVB radiation, this provides this ingredient with a broad spectrum and it explains why it is highly used in different products such as lip balms, lipsticks, and moisturizers. Its protective effective action does not cover completely the UVA rays as it only reaches 336 nm. This has been proven even thought meradimate has a theoretical protective coverage range between 200-380 nm. Its function is related to the intrinsic structure of meradimate which is an ortho-disubstituted aminobenzoate. This structure allows easy electron delocalization and shifts in the maximum absorption.
Related Excipient Companies
Excipients by Applications
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Menthyl Anthranilate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Menthyl Anthranilate, including repackagers and relabelers. The FDA regulates Menthyl Anthranilate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Menthyl Anthranilate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Menthyl Anthranilate supplier is an individual or a company that provides Menthyl Anthranilate active pharmaceutical ingredient (API) or Menthyl Anthranilate finished formulations upon request. The Menthyl Anthranilate suppliers may include Menthyl Anthranilate API manufacturers, exporters, distributors and traders.
Menthyl Anthranilate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Menthyl Anthranilate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Menthyl Anthranilate GMP manufacturer or Menthyl Anthranilate GMP API supplier for your needs.
A Menthyl Anthranilate CoA (Certificate of Analysis) is a formal document that attests to Menthyl Anthranilate's compliance with Menthyl Anthranilate specifications and serves as a tool for batch-level quality control.
Menthyl Anthranilate CoA mostly includes findings from lab analyses of a specific batch. For each Menthyl Anthranilate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Menthyl Anthranilate may be tested according to a variety of international standards, such as European Pharmacopoeia (Menthyl Anthranilate EP), Menthyl Anthranilate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Menthyl Anthranilate USP).
LOOKING FOR A SUPPLIER?